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Abstract
Background: Kawasaki disease is recognized as the most common cause of acquired heart disease in children in the
developed world. Clinical, epidemiologic, and pathologic evidence supports an infectious agent, likely entering through the
lung. Pathologic studies proposing an acute coronary arteritis followed by healing fail to account for the complex
vasculopathy and clinical course.
Methodology/Principal Findings: Specimens from 32 autopsies, 8 cardiac transplants, and an excised coronary aneurysm
were studied by light (n = 41) and transmission electron microscopy (n = 7). Three characteristic vasculopathic processes
were identified in coronary (CA) and non-coronary arteries: acute self-limited necrotizing arteritis (NA), subacute/chronic
(SA/C) vasculitis, and luminal myofibroblastic proliferation (LMP). NA is a synchronous neutrophilic process of the
endothelium, beginning and ending within the first two weeks of fever onset, and progressively destroying the wall into the
adventitia causing saccular aneurysms, which can thrombose or rupture. SA/C vasculitis is an asynchronous process that can
commence within the first two weeks onward, starting in the adventitia/perivascular tissue and variably inflaming/
damaging the wall during progression to the lumen. Besides fusiform and saccular aneurysms that can thrombose, SA/C
vasculitis likely causes the transition of medial and adventitial smooth muscle cells (SMC) into classic myofibroblasts, which
combined with their matrix products and inflammation create progressive stenosing luminal lesions (SA/C-LMP). Remote
LMP apparently results from circulating factors. Veins, pulmonary arteries, and aorta can develop subclinical SA/C vasculitis
and SA/C-LMP, but not NA. The earliest death (day 10) had both CA SA/C vasculitis and SA/C-LMP, and an ‘‘eosinophilictype’’ myocarditis.
Conclusions/Significance: NA is the only self-limiting process of the three, is responsible for the earliest morbidity/
mortality, and is consistent with acute viral infection. SA/C vasculitis can begin as early as NA, but can occur/persist for
months to years; LMP causes progressive arterial stenosis and thrombosis and is composed of unique SMC-derived
pathologic myofibroblasts.
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characteristic of vasculitis in Kawasaki disease is proliferative
granulomatous inflammation consisting of markedly accumulating
monocytes/macrophages’’, ‘‘Secondly, vasculitis in Kawasaki
disease starts simultaneously with the onset, rapidly reaches an
inflammation peak, and then slowly remits and heals with
cicatrization, showing a monophasic course.’’ It was stated that
‘‘the course of Kawasaki disease was synchronous throughout the
body’’ [22].
We studied KD specimens from autopsies (n = 32), explanted
hearts (n = 8), and an incidentally detected CAA resection by light
(LM) and transmission electron microscopy (TEM), and identified
a vasculopathic scheme unlike any previously described
[19,20,22]. Our study identified three distinct but linked basic
KD vascular processes: necrotizing arteritis (NA), subacute/
chronic (SA/C) vasculitis, and luminal myofibroblastic proliferation (LMP).

Introduction
Kawasaki disease (KD) is virtually as enigmatic today as it was
when first reported as ‘‘mucocutaneous lymph node syndrome’’ in
Japan in 1967 [1]. It is likely not a new disease, since subsequent
studies demonstrated that cases diagnosed as ‘‘infantile periarteritis nodosa’’ were actually KD [2,3]. It is referred to as a ‘‘selflimited acute vasculitis’’, which predominantly strikes children
three months to five years of age. It is especially common in Japan,
where 1% of children develop the disease by age 5 [4], but it is also
common in other Asian countries. With control of rheumatic heart
disease, KD is recognized as the most common acquired
childhood heart disease in developed nations. However, the true
worldwide incidence, morbidity, and mortality will remain
unknown until a diagnostic test is developed.
Although after 45 years, the exact etiology of KD remains
unknown, the clinical, epidemiologic, and pathologic evidence
supports a ubiquitous, possibly ‘‘new’’ infectious agent that likely
causes only an inconsequential pulmonary infection, except in those
children with a genetic predisposition for KD [5]. The respiratory
prodromal infection appears to be due to an RNA virus, which
creates persistent intracytoplasmic inclusion bodies in ciliated
bronchial epithelium, and likely disseminates via macrophages to
target medium sized arteries, most critically the coronaries [6]. The
intracytoplasmic inclusion bodies manifest amphophilic staining by
H&E (suggesting the presence of both protein and nucleic acid) and
stain for RNA, but not DNA [6]. TEM of bronchial epithelium
from three patients revealed virus-like particles associated with the
intracytoplasmic inclusion bodies [7].
Although timely treatment with intravenous gamma globulin
(IVIG) plus aspirin has profoundly reduced the prevalence of
coronary artery damage [8,9,10], approximately 10–20% of
patients fail therapy [11,12,13,14,15,16] and are at an increased
risk of developing coronary arteriopathy. Misdiagnosed cases and
children not treated in a timely fashion or at all, including those
who present with incomplete signs and symptoms (‘‘atypical KD’’),
represent a serious problem of unknown dimensions. Recent use of
Z-scores based on body surface area calculations to determine
normal coronary artery measurements has led to the realization
that coronary artery dilation is likely more prevalent and
potentially more severe than previously appreciated [17,18].
Inexplicably, infants less than one year and children over 8 years
of age apparently have the highest prevalence of coronary
pathology [4]. In 2007–2008 alone, 59 Japanese children with
KD developed giant coronary artery aneurysms (CAA), considered
the most dangerous type of coronary artery (CA) pathology [4].
Therefore, both treated and untreated KD children still develop
serious heart disease.
Early gross and light microscopic autopsy studies attempted to
identify the characteristic CA histopathology, a chronology, and
establish clinical:pathologic correlation. They were confounded by
the complexity of the vasculitis, which typically varies from vessel
to vessel of the same patient, among sections from the same vessel,
and even around the circumference of a single section [19,20,21].
The initial studies described microvessel edema followed by a
medium-sized arteritis comprised of neutrophils, lymphocytes, and
large mononuclear cells progressing to panarteritis, and elastic
lamina and smooth muscle cell (SMC) destruction leading to
aneurysm formation. This pathology was observed in the first two
months after KD onset and reported to be followed by resolution
of the inflammation and fibrous scar formation, leading to CA
stenosis in some cases [19,20].
A 2010 review summarized what the authors described as
‘‘consistent among Japanese researchers’’: ‘‘Firstly, the histological
PLoS ONE | www.plosone.org

Methods
Ethics Statement
The study was approved by the Institutional Review Board of
Children’s Memorial Hospital and tissues were de-identified to
maintain confidentiality.

Patients and Tissues
The patients are described in Table 1; all specimens were
studied by light microscopy. Seven cases studied by TEM were
either retrieved from prolonged formalin fixation or from paraffin
blocks. Cases were located when a family member contacted us,
through discussion with colleagues, or occasionally via published
reports. This collection represented a random sample of KD
patients who died, received cardiac transplants, or in one case,
underwent surgical excision of an asymptomatic coronary artery
aneurysm. While two cases (1 and 6) had only a single available
H&E-stained CA/myocardial section, most had multiple CA and
organ sections, the original blocks from the autopsy or transplanted heart, or portions of the formalin-fixed autopsy tissue. Cases 4
[23], 17 and 36 [2], 21 and 22 [24], and 24 [25] were previously
published.

Antibodies and Light Microscopy Stains
Histochemical staining and immunohistochemistry (IHC) were
performed in a certified pathology department histology laboratory using standard techniques. Masson trichrome, elastin vanGieson, macrophage (CD68), Factor VIII-related antigen, and
alpha-smooth muscle actin (SMA) (Dako) stains were utilized with
appropriate controls. Elastin van-Gieson highlights the internal
(IEL) and external elastic (EEL) lamina, the fine elastin fibrils of
the media, and the coarse fibers of endocardial fibroelastosis. SMA
highlights medial and adventitial SMC and LMP myofibroblasts.
Myofibroblasts often dually stained with trichrome; peripheral red
for actin and central blue for the extracellular matrix (ECM)
precursors within the rough endoplasmic reticulum (RER). The
LMP ECM variably stained blue with the trichrome stain and pink
with the H&E stain.
Depending on their availability, tissue/vessels and blocks were
repeatedly re-sectioned and stained to determine the extent and
features of the vascular involvement.

TEM
Un-embedded formalin-fixed and paraffin-embedded tissue was
trimmed for areas of greatest interest and cut into pieces of 1 mm
or less for resin embedding. Retrieval from paraffin for TEM was
performed as previously described [26]. Resin embedding
2
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Table 1. Demographic and clinical data on Kawasaki Disease patients in this study.

Case

Age

Time since onset (yr of
specimen)

Sex

Ethnicity

KD Therapy

Specimen

1

3 yr

10 days (1970s)

U

Japanese

None

Autopsy-CA

2

10 yr

13 days (1994)

M

Caucasian

IVIG, A, W

Autopsy-CA

3

3 yr

2 wks (1995)

M

Caucasian

IVIG, A

Transplant

4

11 mo

2.5 wks (1997)

M

Caucasian

None

Autopsy

5

22 mo

2.5 wk (1976)

M

Caucasian

None

Autopsy

6

3 mo

2.5 wk (1974)

F

Caucasian

None

Autopsy-CA

7

4 mo

3 wk (2000)

M

Caucasian

IVIG, A

Autopsy

8

8 mo

3 wk (1995)

F

U

None

Autopsy

9

21 mo

3 wk (1985)

F

U

A, D, H

Autopsy

10

7 mo

3.5 wk (1978)

F

Caucasian

None

Autopsy

11

3.5 mo

3–4 wk (2006)

M

Caucasian

IVIG, A, S

Autopsy-TEM

12

4 mo

3–4 wk (1971)

M

Caucasian

None

Autopsy-CA

13

4.5 mo

4 wk (2008)

M

Hispanic

IVIG, A, I, S, H,W

Autopsy-TEM

14

4 mo

4 wk (1997)

M

Hispanic

None

Autopsy

15

7 mo

4 wk (1982)

F

Caucasian

None

Autopsy

16

10 mo

4 wk (1984)

F

AA

A, D

Autopsy

17

6 mo

4–5 wk (1974)

M

Caucasian

S

Autopsy

18

4 mo

5 wk (2005)

M

U

IVIG, A, S, H, W

Autopsy-CA

19

2 mo

5 wk (2001)

M

Caucasian

IVIG,A,S,H, ECMO

Autopsy

20

3.5 mo

6 wk (2002)

M

Japanese-American

None

Autopsy-CA

21

4 mo

6 wk (1986)

F

Caucasian

A, H

Autopsy

22

6 mo

6.5 wk (1997)

M

Asian

IVIG, A, S, C, D, H, W,T

Autopsy

23

4 mo

2 mo (1999)

F

Caucasian

IVIG, A, S, M, H

Autopsy

24

6 mo

3 mo (1993)

M

Caucasian

IVIG, A

Transplant

25

2 yr

4.5 mo (2009)

F

Greek

IVIG, A

Autopsy-CA

26

6 yr

5 mo (2008)

M

Caucasian

None

Transplant-TEM

27

5 yr

7.5 mo (2008)

F

Caucasian

IVIG, A, I, prolonged S

Autopsy-TEM

28

19 mo

10 mo (1998)

M

AA

None

Autopsy

29

5 yr

1 yr (2000)

M

Caucasian

None

Autopsy

30A

19 mo

15 mo (1994)

F

Caucasian

IVIG, A

30B

12 yr

11.5 yr (2005)

Transplant 1-TEM
Transplant 2

30C

16 yr

14 yr (2007)

31

8 yr

16 mo (1993)

F

Asian-American

IVIG, A

Transplant 3-TEM
Thoracic autopsy

32

2 yr

18 mo (1999)

M

Caucasian

A, W

Transplant-TEM

33

3 yr

2 yr (2000)

M

U

U

Transplant

34

19 yr

16 yr (2008)

M

Hispanic

None

CA excision-TEM

35

22 yr

19 yr

F

Hispanic

A

Autopsy

36

13 wk

U (1972)

F

Caucasian

U

Autopsy

37

14 mo

U (2002)

M

U

U

Transplant

38

17 mo

U (1997)

M

U

U

Transplant

39

11 yr

U (1999)

M

Caucasian

IVIG, A

Autopsy

40

11 mo

U (1954)

F

Caucasian

None

Autopsy

41

7 mo

U (1959)

F

Caucasian

None

Autopsy

CA = coronary arteries, TEM = transmission electron microscopy, IVIG = intravenous gammaglobulin, A = aspirin, AA = African-American, U = unknown,
S = methylprednisolone/steroid, W = warfarin, H = heparin, D = dipyridamole, I = infliximab, ECMO = extracorporeal membrane oxygenation, C = cyclophosphamide,
M = methotrexate, T = tissue plasminogen activator.
doi:10.1371/journal.pone.0038998.t001
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medium sized non-coronary (i.e., axillary, inter-costal/intervertebral, iliac, mesenteric) muscular and elastic arteries. The
inflammatory cells are neutrophils and the necrotic wall/tissue is a
combination of neutrophils, cellular debris, and fibrin. The
remaining adventitia, pericardial, and peri-vascular tissue of the
CAA invariably measured less than 1 mm in thickness. In some
instances, the aneurysmal vessel consisted of only some pericardial/peri-vascular tissue. Free wall aneurysms were more likely to
rupture than those ‘‘reinforced’’ by lateral tissue and/or myocardium. Although necrosis often approached adventitial vessels, focal
hemorrhage was rare and appeared to be inconsequential. There
was no evidence that NA ever involved small extra- or intraparenchymal arteries or pulmonary arteries, aorta, or veins.
NA was a self-limited process, essentially complete within two
weeks after onset, a time when specimens are inherently rare.
However, many patients who died later had evidence of previous
CA and NCA necrosis. Only adventitia remained after NA; the
other arterial layers had been sloughed. The residual adventitia
could have scattered neutrophils. There was no evidence that NA
commenced or recurred after day 14.
The sections from the patient who died on day 13 (Case 2) from
a ruptured left anterior descending CAA showed waning NA in
the vicinity of the rupture site (Figures 2A, 2B, 2C). He had been
diagnosed 24 hours before death, at which time he received IVIG
and aspirin. Oblique sections of the ruptured tortuous left anterior
descending artery demonstrated the complexity of KD vasculitis/
vasculopathy. Closest to the rupture site, there was a mixture of
neutrophils and necrotic debris extending from the lumen into the
adventitia. Further away, the debris had sloughed and replaced by
fresh clot. Other areas displayed active SA/C inflammation and
SA/C-LMP lesions. In many KD patient CA, post-NA and active
SA/C vasculitis were present simultaneously at different locations
along the same and different CA and NCA.

routinely started with 8 blocks, and proceeded by multiples of 8,
until adequate and desired sampling was achieved. Semi-thin, one
micron resin LM sections were cut with glass knives and stained
with our routine methylene blue/azure II and basic fuchsin
‘‘trichrome’’ stain [26]. Ultra-thin sections were cut with a
diamond knife from blocks selected for TEM, contrasted with
uranyl acetate and lead citrate, and examined with a LEO EM10
transmission electron microscope operating at 60 kV.

Results
The earliest death in our series was in a child with CA
vasculopathy and interstitial ‘‘eosinophilic-type’’ myocarditis (Case
1, day 10) (Table 2). The six deaths from ruptures of CAA were
early, between days 13 and 21, due to saccular aneurysms caused
by NA and composed of varying amounts of preserved adventitia
only.
Myocardial infarction (MI) due to thrombosed saccular CAA
was the most common cause of death, occurring in 23 patients;
two additional patients received transplants for myocardial
infarction due to thrombosis. The time from KD onset to MI
was known for 19 of these 25 cases and ranged from 19 days to 2
years.
Six patients had MI due to stenosis from SA/C-LMP without
detectable thrombi; three of these did not have saccular CAA.
They occurred between 4.5 months and 19 years after onset, with
5 of 6 occurring within two years, similar to the timing of the MIs
in the 19 patients with thrombosis of saccular CAA.
The other two deaths were due to a ruptured iliac aneurysm
(case 13) and a thrombosed mesenteric artery (case 11). At
autopsy, these patients also had severe CA disease that soon could
have been critical. The final patient had an incidental CAA (case
34) resected at 16 years after onset.
Early into the study, it became clear that our observations did
not readily conform to the previously described histopathology or
chronology [19,20,21,22]. Previously published light micrographs
often demonstrated histopathology similar to what we observed,
but the descriptions and interpretations differed markedly, leading
to alternative conclusions. Our findings are most similar to those of
Amano et al [27].
Three distinct basic vasculopathic processes were consistently
demonstrated in the CA and medium-sized muscular and elastic
non-coronary (NCA) arteries of our patients: NA, SA/C vasculitis,
and LMP (Table 2). All three processes were present in the CA
sections from the patient who died from a CAA rupture that
occurred within the first two weeks after fever onset (Case 2, day
13). The first death (Case 1, day 10) was in a patient who had both
‘‘eosinophilic-type’’ interstitial myocarditis and CA SA/C inflammation with LMP; NA was not present in the several available
sections from a single CA.
Fibrinoid necrosis was not observed in our material. However,
layers of fibrin, which stained homogeneously eosinophilic
(‘‘hyaline’’) by H&E and lacked necrotic debris, were observed
and could be mistaken for fibrinoid necrosis.
Each case was evaluated as a challenge to the three process
scheme, and all were confirmatory.

Process 2
SA/C vasculitis is an asynchronous non-neutrophilic
inflammatory
process
predominantly
of
small
lymphocytes and is closely associated with LMP
lesions. It can begin in the first 2 weeks but is also observed

for months to years after diagnosis (Figures 2D, 3, 4, 5, 6, 7, 8, 9).
SA/C vasculitis and its associated LMP (SA/C-LMP) process were
observed in the coronary arteries of all 41 cases, even at day 10
(Case 1, Figure 9B). In cases where more vascular tissue was
available, a greater extent of CA and NCA involvement was
documented. Small epicardial CA could have from no to severe
SA/C vasculitis and SA/C-LMP. Intra-myocardial vessel SA/C
inflammation was minimal and random. There did not appear to
be any mid-sized muscular or elastic artery that escaped SA/C
and SA/C-LMP, with the exception of the central nervous system,
which never displayed evidence of any of the three processes.
Some cases had relatively mild cerebrovascular infiltrates of
predominantly lymphocytes not associated with parenchymal or
vascular pathology. The most frequently involved non-coronary
arteries were renal, mesenteric, axillary, iliac, peri-pancreatic, and
hepatic. There were infarcts of the kidneys, adrenals, and spleen
that were apparently asymptomatic at the time of death. Although
SA/C and SA/C-LMP frequently involves veins (epicardial or
otherwise), pulmonary arteries, and the aorta, the degree of
involvement was relatively minimal, there were no associated
thrombi or apparent clinical significance. Two autopsy reports
described multiple sub-renal aortic aneurysms of less than one
centimeter in diameter; unfortunately no blocks/sections or photos
were available from these aneurysms.

Process 1
NA is an acute synchronized neutrophilic process of midsized arteries that is responsible for the saccular
aneurysms that could either thrombose or rupture within
the first month (Figures 1, 2A, 2B, 2C). NA starts at the

endothelium and sequentially destroys the intima, IEL, media,
EEL, and varying amounts of the adventitia of coronary and
PLoS ONE | www.plosone.org
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Table 2. Pathologic findings in patients with Kawasaki Disease.

Time since
Case onset
Cause of death/TX

CA pathology

Non-CA pathology

Myocardium

Comments

1

10 days

Myocarditis

SA/C-LMP

N/A

‘‘Eosinophilic
myocarditis’’, marked
edema, no necrosis or
PMNL

Several slides from one block

2

13 days

Ruptured LAD CAA

Waning necrotizing
arteritis, thrombosed.
SA/C-LMP LAD

Intra-renal SA/C

3

2 wks

Ruptured LCAA, TX

CABG & over-sewn hole,
no SA/C- LMP visible

N/A

Acute hemorrhagic MI,
PMNL. MI subacute, GT

Free wall atrophy

4

2.5 wk

Ruptured giant LAD
CAA

Giant CAA LAD, x2
RCA. SA/C-LMP

N/A

Large acute MI,
no PMNL

Acute pancreatitis and splenitis

5

2.5 wk

Ruptured left
main CAA

RCAA thrombosed.
SA/C-LMP

SA/C testicular artery

Acute MI, PMNL

Severe acute pancreatitis, adrenal
medullary calcification, thymic
atrophy

6

2.5 wk

MI

CAA RCA, LAD,
thrombosed. SA/
C-LMP LAD occluded

By report: SA/C-LMP, renal,
peri-esophageal, mesenteric,
peri-uterine, ovarian,
peri-adrenal

Subacute MI, GT

One slide

7

3 wk

MI

Thrombosed CAA.
SA/C-LMP

SA/C-LMP aortic,
testicular

Acute MI, no PMNL
or necrosis

Marked pericarditis, thymic
necrosis, acute splenitis, TV
valvulitis

8

3 wk

Ruptured CAA

CAA, fresh & organizing
thrombi, calcified.
SA/C-LMP

N/A

Edema, atrophy

Mild peri-ductal chronic
pancreatitis. Few sections

9

3 wk

Ruptured giant
LAD CAA

Fresh thrombi, LAD,
LCx, RCAA

SA/C-LMP, iliacs.

Acute MI, PMNL

CAAs, long, sausage-shaped

10

3.5 wk

MI

RCAA fresh thrombus.
LCA SA/C-LMP

SA/C-LMP, acute renal
thrombosis

Pseudo-myocarditis

Thymic calcification, renal infarct

11

3–4 wk

Thrombosed mesenteric
aneurysm, organizing,
recanalized, SI infarct

Aneurysms, CAAs.
Fresh thrombus RCAA.
Severe SA/C-LMP

Thrombosed aneurysms,
inter-costal, femoral, axillary,
splenic. SA/C-LMP, hepatic,
skin aortic, adrenal, renal,
thymus. Ilial artery thrombosed,
organizing, recanalizing

Extensive MI, PMNL,
necrosis.

SA/C-LMP veins, Renal, adrenal
infarcts, terminal ileum necrosis

12

3–4 wk

MI

CAAs fresh & organizing
calcified thrombi. Long
dilated thrombosed CAs
with SA/C-LMP to 95%

N/A

Extensive subacute
MI, GT. Propagating
acute necrosis, no
PMNL

13

4 wk

Ruptured RCIAA

Multiple CAA,
SA/C-LMP CAs

SA/C-LMP hepatic, renal, illiacs
prostatic. Aneurysms CIAs,
axillary

Mild interstitial fibrosis.
No acute ischemia

Five distal aortic aneurysms up to
8 mm

14

4 wks

MI

CAAs, LAD, LCx
thrombosed.
SA/C-LMP, severe

Aortitis

Focal subacute
MIs, GT

Viral-type pneumonia, heart
failure

15

4 wk

Massive MI

CAA, LAD, RCA,
thrombosed. SA/C,
no LMP

SA/C-LMP cystic duct artery

Acute MI, PMNL.
Mural thrombi.
Mitral insufficiency

Gallbladder hydrops, chronic
pancreatitis, central liver necrosis

16

4 wk

MI

CAAs, RCA, LCA,
LAD, LCx, thrombosed

SA/C-LMP marked, all organs,
stenotic with thrombi, aortitis

MI subacute, GT.
Interstitial SA/C

Concurrent group B Salmonella
sepsis. Most CAA and non-CA
disease seen in our cases

17

4–5 wk

MI

CAAs, LAD, LCX, RCA,
large fresh thrombi,
SA/C-LMP

SA/C-LMP, epididymis,
pancreas

Massive acute MI,
odd-shaped, not
confluent, no PMNL

Cholangitis, pericarditis, thymic
involution

18

5 wk

MI

Acute thrombosis
LCxCAA, RCAA,
SA/C-LMP

N/A

Acute ischemia, no
PMNL

Vavulitis

19

5 wk

MIs

Giant LAD CAA, fresh
& organizing thrombi,
calcified, recanalized,
RCAA, SA/C-LMP,
severe

SA/C-LMP, mesenteric, organizing Extensive nonthrombus. Mild LMP PA, IVC
confluent SA and
healing MIs,
calcifying
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Gallbladder hydrops

‘‘Atypical myocytic process’’.
Generalized calcification,
pigmented macrophages. Rt
carotid thrombosis, collapse, S/P
ECMO
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Table 2. Cont.

Time since
Case onset
Cause of death/TX

CA pathology

Non-CA pathology

Myocardium

Comments

20

6 wk

MI

CAA, fresh, organizing
& organized thrombi

By report: Thrombosed
inter-costal aneurysms.
Thickened iliacs and aortic
bifurcation

Acute ischemia, no
PMNL

Five sections from one CA only

21

6 wk

MI

RCAA fresh thrombus.
SA/C-LMP LAD & LtCx,
organized thrombi

SA/C-LMP & thrombi, renal,
pancreatic, mesenteric, muscle,
iliac, hepatic

N/A

Acute renal, splenic infarcts.

22

6.5 wk

MI

CAA, fresh, organizing,
organized thrombi,
calcified

SA/C-LMP, SMA. LMP
subclavian

Healing MI, GT,
acute propagation,
no PMNL

Necrotic adrenal medullae with
macs. Cholangitis, sialadenitis,
chronic enteritis. Splenic
collections of macrophages

23

2 mo

MI

CAA, RCA, LAD, fresh,
calcified, organizing
thrombi, calcified

SA/C-LMP, renal, femoral,
mesenteric, splenic

Acute MI, no PMNL.
Sub-acute MI, GT

Renal, splenic infarcts.
Hemorrhagic peritonitis

24

3 mo

MI; TX

CAAs, organizing,
organized calcified
thrombi. RCAA, long
fresh thrombus. Focal
SA/C-LMP

N/A

Acute MI, no PMNLs.
Healed MI

TV valvulitis

25

4.5 mo

MI

CAA & SA/C-LMP

N/A

MI, minimal necrosis,
no PMNL

26

5 mo

MI;TX

RCAA no thrombi.
Marked SA/C-LMP

N/A

Focal ischemia,
no PMNL

Minimal epicarditis

27

7.5 mo

MI

Multiple CAA, no thrombi. SA/C-LMP, pancreatic, splenic,
Marked SA/C-LMP RCA,
renal, aortitis, uterine, .90%
LCx, LAD, 90–100%
stenotic, paratracheal occluded
stenosed

Acute necrosis, foci
of PMNL. Calcified
myocytes

Mild cerebral vessel lymphocyte
infiltrate

28

10 mo

MI

SA/C-LMP to 95%
stenotic, one fresh
thrombus

SA/C-LMP, PA, aortitis with
intimal multinucleated
macrophages

Acute necrosis, PMNL.
Interstitial fibrosis.
Myocyte calcification

Valvulitis, PV, MV, TV. Pulmonary
emboli

29

1 yr

MI

Giant CAA, organizing
thrombus. SA/C-LMP
LAD, 4 cm dilation

SA/C-LMP, renal, SI, adrenal,
LN, hepatic, sklt muscle, PA,
thyroid, stomach

Acute necrosis, mild
PMNL. Rare foci of
healing ischemia, GT

30A

15 mo

MI; TX1

RCAA fresh &
organized thrombus.
LCAA organizing
thrombus, calcified.
SA/C-LMP

N/A

Acute ischemia, no
PMNL

Hypertrophied, box-car nuclei

30B

11.5 yr

MI; TX2

CAs to 90% luminal
stenosis

N/A

Massive necrosis, no
PMNL. Mild fibrosis

Mild medial, IEL damage, IEL
reduplicated. Rare intimal foamy
macs, SA/C, prominent
lymphocyte collections

30C

14 yr

CA insufficiency; TX3

Luminal occlusion
LAD, RCA, LCx CA. I
ntimal foamy macs,
SMC. Mast cells

N/A

No acute or chronic
ischemia. Lymphocytic
pseudo-myocarditis

SA/C-LMP veins. Preserved CA
media, IEL

31

16 mo

MI

Lt main CAA
thrombosed.
SA/C-LMP, LCx,
LAD, RCA

N/A

Mild ischemia, no
PMNL. Healed foci
of ischemia

Thorax only

32

18 mo

Chronic ischemia; TX

RCAA. SA/C-LMP,
no thrombi

N/A

Massive scarring.
No inflammation,
acute ischemia

33

2 yr

MI; TX

Lt main CAA, fresh &
organizing thrombi,
calcified

SA/C-LMP, variable stenosis

Large subacute MI, GT.
Trapped coagulation
necrosis, no PMNL

‘‘Atypical myocytic process’’

34

16 yr

Incidental finding
during cardiac
catheterization for
WPW; aneurysm
resected

RCAA. SA/C-LMP

N/A

N/A

IMA graft

35

19 yr

MI

SA/C-LMP to 80%
stenotic

N/A

Acute MI with PMNL
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Table 2. Cont.

Time since
Case onset
Cause of death/TX

CA pathology

Non-CA pathology

Myocardium

Comments

36

U

MI

Thrombosed CAA

No SA/C-LMP

Mild necrosis, PMNL
Atrophy

SA/C, necrosis of MV. Limited
slides

37

U

MI; TX

LADCAA, fresh thrombus. N/A
SA/C-LMP thrombi,
organized, re-canalized,
calcified

Healing and nearhealed MI. Small
acute MI, no PMNL

Prominent, generalized
eosinophils

38

U

MI

Giant CAA LAD, fresh
& organizing, thrombi,
re-canalized, calcified.
RCAA. SA/C-LMP
to 90% stenosis

N/A

Massive acute
necrosis, no PMNL.
Large healing LV
scars with elastosis

Reduplication of LCx IEL

39

U

MI

RCAA, long fresh
thrombus, CAA
thrombus, organized,
calcified

N/A

Necrosis, no PMNL.
Healed MI

TV valvulitis

40

U

MI

CAAs, fresh thrombi

By report: SA/C-LMP, hepatic,
spermatic, retro-peritoneal

Hyper-eosinophilia,
pseudo-myocarditis

By report: necrosis, thrombosis of
choroid plexus, corpus striatum,
calcified. Only heart slides

41

U

MI

Giant CAAs, fresh &
organizing thrombi,
calcified. SA/C-LMP

By report: SA/C-LMP, pancreatic,
mesenteric, renal, peri-aortic,
splenic, skeletal muscle

No acute changes.
Stellate healing
MIs, GT

Only heart slides

RCIA = right common iliac artery, SA/C = subacute/chronic inflammation, CA = coronary artery, CAA = coronary artery aneurysm, LMP = luminal myofibroblastic
proliferation, MI = myocardial infarction, TX = transplant, Mac = macrophage, SI = small intestine, RCA = right coronary artery, LAD = left anterior descending artery,
LCx = left circumflex artery, IMA = inferior mesenteric artery, GB = gallbladder, MV = mitral valve, TV = tricuspid valve, PV = pulmonary valve, GT = granulation tissue,
eos = eosinophils, SMA = superior mesenteric artery, PA = pulmonary arteries, macs = macrophages, PMNL = predominantly neutrophils, U = unknown, N/A = not
available, EFE = endocardial fibroelastosis, ECMO = extracorporeal membrane oxygenation, IVC = inferior vena cava. Notes: CA sections usually contained myocardium,
epicardium, and some endocardium. All patients had active SA/C plus LMP in coronary and also in available non-coronary arteries. Varying degrees of chronic hypoxia
(hydropic change) seen in all cases. Anitschkow cells always seen, if case had at least two sections of myocardium. EFE always seen, if specimens included more than
focal endocardium. By report = slides not available, but description sufficient to derive pathology.
doi:10.1371/journal.pone.0038998.t002

The inflammatory cells of SA/C were predominantly small
lymphocytes, with varying numbers of plasma cells (often in
clusters, but rarely containing Russell bodies) and eosinophils

(including band forms), scattered macrophages, and rare neutrophils. ‘‘Atypical’’ activated mononuclear cells were rarely observed. Granulomas and granulomatous inflammation are neither
features of KD vasculitis nor non-vascular lesions. The only
CD68-positive macrophages observed were apparently in the
process of scavenging medial and adventitial debris resulting from
SA/C vasculitis. SA/C inflammation commenced in the perivascular/adventitial vaso vasorum and progressed luminally
(Figure 5A), in the opposite direction compared with NA.
The degree of SA/C inflammation and accompanying tissue
damage formed a broad spectrum ranging from mild to severely
destructive pan-arteritis/peri-arteritis, which could lead to saccular
CAA and thrombosis. The initial site of vessel inflammation was
frequently quite obvious and appeared to progress circumferentially accompanied by the induced luminal SA/C-LMP, until the
intra-luminal lesion was of relatively equal thickness. When the
inflammation/damage was relatively mild, the media was virtually
intact and IEL and EEL were without evidence of dilation or
distortion. When the degree of inflammation/damage was
somewhat greater, the artery apparently could initially dilate and
then return to its normal morphology/diameter by ‘‘recoiling’’ or
it could remain fixed in a mildly dilated fusiform state, both with
substantial amounts of preserved media and elastic; their SA/C
lesions could progress. At the next level of severity/intensity, the
inflamed/damaged arteries could progressively dilate into a
saccular aneurysm with relatively little remaining IEL, EEL, and
media, and could thrombose. Occasionally, small amounts of
remaining IEL calcified, which enhanced their visualization in
H&E sections.

Figure 1. Kawasaki Disease Vasculopathy, Process 1, Necrotizing Arteritis (NA). NA is an acute self-limited, one-time, synchronous
process complete within about 2 weeks of fever. It starts at the
endothelium of medium sized muscular and elastic arteries and
progresses peripherally; involvement of veins, pulmonary arteries, and
aorta is not observed.
doi:10.1371/journal.pone.0038998.g001
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Figure 2. Necrotizing Arteritis (NA) and severe SA/C pan-arteritis. A. Portion of a CA undergoing NA. The friable fragmenting wall is a
mixture of neutrophils and debris. The adventitia is virtually obscured by inflammation and RBCs. H&E, case 2, original magnification 166. B. Higher
magnification of an area of CA NA predominantly of neutrophils. H&E, case 2, original magnification 636. C. The necrotizing process has reached into
the adventitia, which is only mildly inflamed. H&E, case 2, original magnification 166. D. An area of CAA consistent with having undergone severe SA/
C pan-arteritis, leaving only adventitia rich in SA/C inflammatory cells, almost exclusively small lymphocytes. Note the longitudinally sectioned vessel
and fibrin/RBC lining the luminal surface. H&E, case 11, original magnification 406. L = lumen, ADV = adventitia, V = vessel, F = fibrin, NA = necrotizing
arteritis, N = neutrophils.
doi:10.1371/journal.pone.0038998.g002

SA/C than NA. Some saccular aneurysms developed relatively
minor LMP lesions with little luminal narrowing, apparently
because destruction of the media limited the available SMC for
transition to myofibroblasts. While the first saccular CAA
thrombosis caused by either NA or SA/C could be fatal,
alternatively it could start organizing, and there could be
additional thrombotic episodes, any one of which could be fatal.
The commencement of SA/C saccular aneurysm formation
occurred in the first 1–2 months, while thrombosis could occur
at any time.

Arteries that experienced the most severe SA/C arteritis
underwent a form of necrosis whereby the vascular wall resembled
layers of a peeling onion, but without neutrophils. In contrast to
saccular CAA resulting from NA, after SA/C there were often
some foci of preserved media and IEL. The remaining adventitia
contained varying amounts of SA/C inflammation. The resulting
saccular CAA frequently thrombosed but apparently did not
rupture. Thus, while fusiform CAA are due to SA/C inflammation, saccular CAA can be due to either NA or severe SA/C. More
saccular CA and NCA aneurysms appeared to be due to severe
PLoS ONE | www.plosone.org
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Figure 3. Kawasaki Disease Vasculopathy, Process 2: Subacute/Chronic (SA/C) Vasculitis. A ubiquitous, asynchronous inflammatory
process that can begin as early as the first two weeks, and targets medium-sized muscular and elastic arteries. Inflammatory cells: small
lymphocytes..eosinophils & plasma cells.. macrophages. Minimal (subclinical) involvement of veins, pulmonary arteries, & aorta. Triggers Process
3, luminal myofibroblastic proliferation (LMP).
doi:10.1371/journal.pone.0038998.g003

The child (Case 13) who died from a ruptured iliac artery
aneurysm between 4 and 5 weeks had evidence of both severe SA/
C inflammation/damage and post-NA changes, with sloughing of
necrotic debris. Iliac artery sections also showed varying degrees of
stenosing SA/C-LMP lesions.
Another child (Case 11) who died from a myocardial infarction three
to four weeks after presentation had a single CA plus several NCA that
were in the process of extreme SA/C arteritis, accompanied by
sloughing and aneurysm formation. An axillary artery aneurysm
contained a friable thrombus with no evidence of organization. Two
inter-costal/inter-vertebral arteries were in the process of shedding
their media and part of their adventitia and were already quite dilated.
One CAA section showed post-NA features.

Process 3
LMP is a progressive asynchronous intra-luminal
stenosing process of SMC-derived myofibroblasts of the
type described in wound healing by Gabbiani [28] plus their
matrix products and SA/C inflammation (SA/C-LMP). It

is neither granulation tissue nor does it show organization,
‘‘remodeling’’, or recanalization (Figures 4, 5, 6, 7, 8, 9, 10, 11,
12, 13, 14).
The lesions were typically circumferential and relatively
symmetric, ultimately leaving a slit-like lumen (Figure 7). Longitudinal and tangential sections could display a variably attached
obstructing SA/C-LMP lesion extending free within the lumen.
Determining the full extent and degree of the luminal lesions

Figure 4. Kawasaki Disease Vasculopathy, Process 3: Luminal Myofibroblastic Proliferation (LMP). A process triggered locally and
apparently remotely by Process 2 that can progress to total occlusion. LMP myofibroblasts are ultrastructurally, but not functionally, similar to wound
healing myofibroblasts.
doi:10.1371/journal.pone.0038998.g004
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Figure 5. Subacute/Chronic (SA/C) Inflammation in KD CAA. A. SA/C inflammatory cells extending from the adventitia of a CA has almost
reached the IEL. The EEL and most of the media are obscured/destroyed by the SA/C. The lumen contains a mixture of RBC, fibrin, and lysing
leukocytes, that could indicate the beginning of a clot. H&E, case 11, original magnification 406. B. The CA adventitia and media are rich in SA/C
inflammatory cells. The thick inflammation of SA/C-LMP has obscured most of the myofibroblasts. There is more collagen staining (blue) in the
adventitia than protein staining of the ECM of the SA/C-LMP. Note the increase in cellular concentration toward the lumen. Trichrome stain, case 18,
original magnification 166. C. The alpha-SMA stains SMC and vessels in this CA adventitia, SMC in the media, and MF in the SA/C-LMP. Focal areas of
IEL remain. Alpha-smooth muscle actin (SMA) immunohistochemistry (IHC), case 18, original magnification 106. D. At higher magnification, SMCs
appear to be entering the media from the adventitia, while large myofibroblasts exit the luminal side into the SA/C-LMP. SA/C inflammation is
present in all three layers. Alpha-SMA IHC, case 18, original magnification 636. M = media, SMC = smooth muscle cells, MF = myofibroblast,
ADV = adventitia, IEL = internal elastic lamina, LMP = luminal myofibroblastic proliferation, L = lumen, V = vessel, P = pericardium.
doi:10.1371/journal.pone.0038998.g005

blast content, and proliferative nature, it seems more appropriate
to use the term ‘‘luminal myofibroblastic proliferation’’. Based on
the intimate association, the SA/C inflammatory process appears
to be key to LMP development.
Interestingly, it was not unusual to see arterial sections with mild
to totally occlusive LMP or media pathology that displayed little to
no apparent SA/C inflammation. This could indicate that the
inflammation was out of the plane of section, had resolved over

requires examining multiple sequential cross sections (‘‘breadloafing’’). SA/C was documented in over 20 different arteries in
our cases, varying somewhat from patient to patient.
Historically, the luminal lesions of KD have been considered to
arise from the intima/sub-intima; however, this area is typically
denuded by the SA/C inflammatory process. LMP lesions directly
abut either the IEL or the media, depending on the status of the
IEL. Therefore, considering its intraluminal location, myofibroPLoS ONE | www.plosone.org
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Figure 6. Luminal Myofibroblastic Proliferation (LMP) in KD CAA. A. The peri-luminal portion of the CA SA/C-LMP is rich in polygonal shaped
myofibroblasts, while elsewhere the myofibroblasts are more pleomorphic. The background is mostly small lymphocytes. Alpha-SMA IHC, case 18,
original magnification 636. B. At higher magnification, the myofibroblasts in this area of SA/C-LMP resemble a culture of pleomorphic mesenchymal
cells. The SA/C background is especially rich in small lymphocytes. Alpha-SMA IHC, case 13, original magnification 1006. C. The LMP resembles a
‘‘syncytium’’ of pleomorphic MF with red-staining actin and blue-staining pro-collagen. SA/C nuclei stain dark red. There is some blue staining of the
ECM. The luminal lining (top) consists of RBCs and dark red staining fibrin. Trichrome stain, case 13, original magnification 1006. D. The SA/C-LMP
contains large, pleomorphic myofibroblasts with large nuclei and several small nucleoli. The ECM is difficult to delineate. Trichrome stained plastic
section, case 13, original magnification 1606. L = lumen, MF = myofibroblast, LMP = luminal myofibroblastic proliferation.
doi:10.1371/journal.pone.0038998.g006

time without leaving media damage, or that active SA/C
inflammation in a distant part of the same or another vessel was
involved in producing circulating factor(s) that could cause
development of LMP at remote locations. LMP lesions could be
associated with thrombosis.
All transplanted hearts had CAA, myocardial infarctions of
varying vintages, and SA/C-LMP lesions. A few had fresh CA
thrombi, while one had a ruptured CAA.

PLoS ONE | www.plosone.org

SA/C-LMP was present in the asymptomatic CAA resected 16
years after acute KD (Case 34). Since the available sections
showed some surviving media and IEL, the CAA had likely been
caused by SA/C pan-arteritis and not NA.
SA/C-LMP lesions most resemble what was described in KD
pathology studies from the 1970s as stages 4 and 5 [19] or stage
III [20], and are consistent with the progressive luminal
narrowing that has been referred to variably as intimal
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Figure 7. SA/C-Luminal Myofibroblastic Proliferation (LMP) causes narrowing of CA in KD patients. A. A tear drop-shaped CA with SA/CLMP is about 50% narrowed. The actin-rich myofibroblasts and medial and adventitial SMCs stain brown. The residual media is variably thinned.
Alpha-SMA IHC, case 11, original magnification 106. B. Oval-shaped SA/C-LMP CA is virtually occluded. The MF and medial SMC stain red and there is
a relatively little ECM (blue) in the LMP. Except for some thinning, the media is almost completely intact. The adventitia is densely collagenized.
Trichrome stain, case 28, original magnification 106. C. The SA/C-LMP in this elongated CA is eccentric having started at the end (top) where the
media and IEL had been destroyed and progressed toward the end, which still contains media and IEL (bottom). H&E, case 26, original magnification
106. D. An oval CA is occluded by SA/C-LMP, of relatively low SA/C cellularity concentrated around the lumen. There are several small areas of
minimally preserved media. No media is present on the side with the hyper-vascular adventitia, where the process likely began. H&E, case 27, original
magnification 106. E. The SA/C-LMP progressed from the inflamed/damaged end (bottom) of this tangentially-sectioned renal artery almost reaching
the opposite end (top), where the lumen is visible and there is intact media and IEL are intact. H&E, case 27, original magnification 106. L = lumen,
M = media, ADV = adventitia, LMP = luminal myofibroblastic proliferation, RBC = red blood cells, IEL = internal elastic lamina, V = vein, I = inflammation,
T = renal tubules, P = pericardium, My = myocardium.
doi:10.1371/journal.pone.0038998.g007

hyperplasia, fibro-cellular thickening of the intima, intimal
fibrosis or proliferation, granulation, obliterative panarteritis,
and smooth muscle or fibro-intimal hyperplasia, hypertrophy, or
thickening. These terms are based on H&E and occasional
histochemical stains, without LM of semi-thin resin sections,
TEM or IHC.

PLoS ONE | www.plosone.org

The SMC-derived Myofibroblast of KD LMP Behaves
‘‘Pathologically’’
The pathognomic cell of LMP is neither a fibroblast nor a
SMC, although relatively small numbers of either or both of these
cells can also be present. Even though it is SMC-derived, the LMP
myofibroblast has the classic ultrastructural features of the
12
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Figure 8. Thrombi in coronary artery aneurysms (CAA) of KD patients. A. A CA already severely compromised by SA/C-LMP is virtually
occluded by a superimposed fresh thrombus (dark red) that blends into the SA/C-LMP. Trichrome stain, case 18, original magnification 166. B. Part of
a NA CAA occluded by a fresh thrombus. There is a small area of organizing thrombus. Since only mildly inflamed fibrotic adventitia remains, it is not
possible in this section to distinguish between NA and SA/C as the etiology. H&E, case 11, original magnification 106. C. A small portion of CAA
thrombus. The vascular granulation tissue has a loose matrix containing few free RBC, spindle cells and mononuclear cells, a few of which are
macrophages containing brown hemosiderin blood pigment. Spindle cells are reaching into the luminal RBCs. H&E, case 22, original magnification
636. D. The oldest peripheral thrombus in this CAA is re-canalizing. There are superimposed fresher thrombi. Since the CAA still has some remaining
media, the aneurysm likely resulted from severe SA/C pan-arteritis. H&E, case 37, original magnification 106. E. This organized SA/C CAA thrombus
has peripheral clumps of calcium. Some of the media is still visible (upper right). H&E, case 19, original magnification 166. L = lumen, LMP = luminal
myofibroblastic proliferation, M = media, ADV = adventitia, ORG = organizing thrombi, R = recanalized, Ca = calcium, V = vessel.
doi:10.1371/journal.pone.0038998.g008

pathognomonic fibroblast-derived wound healing myofibroblast
described by Gabbiani [28]. The stimulus for LMP and wound
healing myofibroblasts may be similar. However, the LMP
myofibroblast remains activated, causing progressive luminal
narrowing to the point of total obstruction without undergoing
apoptosis, in contrast to the life-saving terminally differentiated
myofibroblast of wound healing.

PLoS ONE | www.plosone.org

While still situated within the media, SA/C-stimulated SMC
enlarge, become increasingly pleomorphic, and produce more banded
collagen and elastin fibers than usual (Figures 10, 11). These
transitioning cells tend to re-orient from circumferential to perpendicular to the media as they migrate luminally either thru pores or gaps in
the IEL, and along with SA/C inflammatory cells, emerge from the
luminal aspect of the media to create enlarging SA/C-LMP lesions.
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Figure 9. Myocarditis. A. Low magnification H&E of a poorly-preserved hourglass-shaped epicardial CA showing varying degrees of SA/C periarteritis, transmural SA/C, and minimal preserved media. H&E, case 1, original magnification 106. B. Perivascular and transmural SA/C inflamed
adventitia and heavily damaged media with some discernible SMC and IEL, and SA/C-LMP with scattered pleomorphic myofibroblasts. There are
some eosinophils intermixed with the small lymphocytes. H&E, case 1, original magnification 166. C. A higher magnification of a typical area of SA/CLMP with prominent amphophilic myofibroblasts in a background of mostly small lymphocytes, scattered eosinophils, and likely macrophages in a
fibrillar ECM that shows some artifactual spaces. H&E, case 1, original magnification 256. D. A typical area of the highly edematous interstitial
myocarditis especially rich in eosinophils, with scattered lymphocytes, macrophages, and plasma cells. Note the longitudinally-sectioned caterpillarshaped and cross-sectioned, owl eye-shaped (unidentified) Anitschkow chromatin pattern in a myocyte and two unidentified cell nuclei, respectively.
H&E, case 1, original magnification 406. L = lumen, NV = nerve, IEL = internal elastic lamina, Eo = eosinophil, AM = Anitschkow myocyte,
MF = myofibroblast, V = vein, ADV = adventitia, M = media.
doi:10.1371/journal.pone.0038998.g009

Extrapolating from the ultrastructure, the SMC to myofibroblast transition can be readily demonstrated by light microscopy in
H&E and trichrome-stained sections and by SMA IHC. Adven-

PLoS ONE | www.plosone.org

titial SMC appear capable of entering the peripheral media, as if
in the act of media re-population. Where there are breaks in the
media/IEL, adventitial SMC appear capable of migrating all the
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Figure 10. Early transitional changes of medial SMC into myofibroblasts. A) Tangential section of media showing variably oriented electron
dense banded collagen (e.g., C). The SMC are somewhat swollen, yet the actin (A)/dense bodies (long red arrows) are still apparent. The external
lamina is obscured by the ECM. The dense plaques (short black arrows) are visible. Case 32, original magnification 5,0006. B) Longitudinal section of
medial SMCs commencing their transition to MF. There is abundant actin (A) with dense bodies (long red arrows), dense plaques (short black arrows),
shedding external lamina (short red arrows), and serrated nuclei. Electron dense banded collagen production has increased, and there is fibronectin
(long black arrows). Higher magnification showed abundant pinocytic vesicles. Case 32, original magnification 4,0006.
doi:10.1371/journal.pone.0038998.g010
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Figure 11. Increase in myofibroblast RER and pleomorphism, as well as intercellular elastin. A) The actin (A)/dense bodies (long red
arrows) share the cytoplasm with RER. The extracellular matrix is composed almost exclusively of haphazardly arranged electron dense banded
collagen. The ECM obscures the dense plaques and external lamina. Pinocytic vesicles (P) are visible. Case 32, original magnification 5,0006. B) Dense
plaques (short black arrows), actin (A), and dense bodies (long red arrows) have decreased and there is more RER. Note the abundant electron dense
intercellular elastin (E), mixed with the collagen. Note the external lamina (long black arrows). Case 32, original magnification 5,0006.
doi:10.1371/journal.pone.0038998.g011

a section where there was also normally located IEL. It is not clear
whether this indicates that the LMP lesion had ceased expanding
and was developing a new intimal lining.
Prolonged post-mortem or surgical hypoxia typically creates
artifacts such as cytoplasmic edema/swelling (hydropic change),
interstitial edema, and sloughing of the endothelium. While in
some specimens ‘‘normal’’ vessels had some remaining endothelial
cells, LMP lesions were frequently lined by one or more layers of
pleomorphic, hyperchromatic, amphophilic H&E staining cells
that were strongly positive for both Factor VIII-related antigen
and SMA (Figure 6A).
Ultrastructurally, the transition of SMC into myofibroblasts is
characterized by a progressive increase in central dilated profiles of

way into SA/C-LMP lesions as they transition into myofibroblasts
(Figure 5D).
The largest, most pleomorphic myofibroblasts tend to be
concentrated near the lumen. However, they can be near the
media or even distributed throughout the entire SA/C-LMP
lesion, giving it the appearance of a culture of pleomorphic
mesenchymal cells. Mitotic myofibroblasts were occasionally
observed, most often in the vicinity of the luminal surface. The
trichrome stain can demonstrate the dual nature of myofibroblasts;
the peripheral actin stains red and the central pro-collagencontaining RER stains blue (Figures 6C, 6D, 7B).
Occasional stretches of a new, ‘‘second’’ IEL can be observed
under the ‘‘endothelial’’ cells lining the luminal surface in areas of
PLoS ONE | www.plosone.org
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Figure 12. Myofibroblast fibronectin, shed external lamina, and intercellular junction. A) There is copious actin (A) with prominent dense
bodies (long red arrows) in this large pleomorphic myofibroblast. The nucleus is also large and irregular. Note the electron dense fibronectin (long
black arrows). The ECM is loose and contains shed external lamina (short red arrows). Case 32, original magnification 5,0006. B) The cell has two
prominent visible cytoplasmic extensions and is shedding strips of external lamina (short red arrows) into a loose stroma of granular-fibrillar ECM,
with no banded collagen. Dense bodies (long red arrow), actin (A) and RER are present within the cell. Case 26, original magnification 5,0006. Inset: A
non-specific junction (JXT) joins two MF. Actin (A) is present with very prominent dense bodies (long red arrows). Case 13, original magnification
10,0006.
doi:10.1371/journal.pone.0038998.g012

RER and a proportional decrease in bundles of actin with dense
bodies (‘‘stress fibers’’) [28] (Figures 10, 11, 12, 13, 14). TEM is the
only definitive means to identify myofibroblasts, since there is no
specific IHC marker. As with wound healing myofibroblasts, the
stress fibers of LMP myofibroblasts are associated with subplasmalemmal dense plaques and electron dense, extracellular,
PLoS ONE | www.plosone.org

fibornectin
filaments
forming
‘‘fibronexus’’
complexes
(Figures 12A, 13B). However, indicative of their SMC origin,
LMP myofibroblasts can maintain varying amounts of external
lamina material and pinocytic vesicles (Figure 10B, 11A).
Mesenchymal or adherens- type junctions are seen, but gap
junctions have yet to be detected. The myofibroblast nuclei vary in
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June 2012 | Volume 7 | Issue 6 | e38998

Three Linked Vasculopathic Processes In KD

Figure 13. Copious cytoplasmic RER and shed external lamina and fibronectin. A) The slightly tangentially sectioned cell has about equal
RER and actin (A) with dense bodies (long red arrows). There is a single large primary lysosome (*), shed external lamina (short red arrows), and
relatively sparse dense plaques (short black arrows). Case 13, original magnification 5,0006. B) A MF with more RER than peripheral actin (A)/dense
bodies (long red arrows). The nucleus is large and irregular with a prominent nucleolus and apparently lost some chromatin during processing. Shed
external lamina (short red arrow) and fibronectin (long black arrow) are prominent. Case 13, original magnification 4,0006.
doi:10.1371/journal.pone.0038998.g013
PLoS ONE | www.plosone.org
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Figure 14. Pleomorphic mono- and binucleated myofibroblasts, abundant RER and SA/C lymphocytes. A) RER dominates the cytoplasm
of this stellate myofibroblast with a complex nucleus and at least two small nucleoli; some actin (A) is present. The matrix contains some shed
external lamina (short red arrows) and fine filamentous collagen. There are typical small lymphocytes (L) with high nuclear to cytoplasmic ratios. Case
13, original magnification 1,7006. B) This MF is bi-nucleated and has very dilated, complicated profiles of RER plus actin (A). The loose ECM is
dominated by shed external lamina (short red arrows). Case 26, original magnification 5,0006.
doi:10.1371/journal.pone.0038998.g014
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Figure 15. Explanted heart (transplant 2) with post-transplant CA vasculopathy showing similar features to those in KD LMP. In
patient 30, the second transplanted heart was removed because of post-transplant vasculopathy; pathologic myofibroblasts were observed in the
luminal lesions of the coronary arteries. This myofibroblast is similar to the one in Figure 10B with its broad irregular processes (right field). It has
extensive dense plaques (short black arrows), abundant actin (A) and some dense bodies (long red arrows). External lamina is both attached and shed
(short red arrows). The loose banded collagen (C) is in the upper left of the field. Case 30C, original magnification 4,0006.
doi:10.1371/journal.pone.0038998.g015

size and shape and contain one or two prominent nucleoli. They
are often in intimate contact as if in the act of fusion, while
occasional bi-nucleated cells are identified (Figure 14B).

by endothelium (Figure 8D). In case 33, a single organized
thrombus contained a complex of several small equal-sized
‘‘mature’’ arteries with intima, media, and adventitia. However,
there was also focal SA/C inflammation and SA/C-LMP, which
was not present in published pictures of similar lesions [29,30,31].
As opposed to the classic form of organized thrombus, these
angiomatoid neo-vessels did not contain blood, and differ from
what is observed in atherosclerosis, organized pulmonary emboli,
and pulmonary hypertension (e.g., plexiform pattern) [32,33]. The
reasons for the two forms of re-canalization are not clear.
Neither SA/C-LMP nor LMP lesions underwent any form of
re-canalization, but could show perpendicularly-oriented, arteriole-size feeder vessels extending from the adventitia through intact
media or media gaps, occasionally reaching the lumen.
A feature virtually exclusive to late organizing or organized
thrombi were aggregates of coarse calcium, often associated with
the re-canalization (Figure 8E). Only a small deposit of calcium
was seen in a single LMP section from one case. Neither medial
nor adventitial calcification was noted in KD, including the
remaining adventitia of CA and NCA aneurysms.
During organization of thrombi, there is an increase in both free
and intra-macrophage golden-brown hemosiderin pigment derived from RBCs that had leaked from the budding capillary bed
(Figure 8C). Hemosiderin pigment appeared capable of persisting
indefinitely in organized thrombi.

The ECM of LMP Lesions
The ECM of the LMP lesions varied in proportion to the
cellularity and staining density as seen by the H&E (pink) and
trichrome (blue) stains (Figures 5,6). Ultrastructurally, it consisted
of variably-oriented and electron dense banded collagens and
loose non-banded collagen fibrils. Parallel rows of banded collagen
fibrils oriented perpendicular to and intimately associated with the
plasma membrane of myofibroblasts were observed, typical of cells
actively producing collagen that polymerizes at the plasma
membrane. Tight arrays of electron dense fibronectin filaments
both extended from the plasma membranes and shed into the
stroma. Lighter staining, finely filamentous/flocculent external
lamina collagen was seen both attached to the plasma membrane
and shed into the stroma. The ECM also contained varying
amounts of glycosaminoglycan particles and elastin fibers
(Figures 10, 11, 12, 13, 14).

Distinguishing SA/C-LMP Lesions from Organizing and/or
Organized Thrombi
Thrombi were seen intercalated into the damaged adventitia of
CAA, SA/C inflamed/damaged vessel walls, or overlying/
blending into the luminal surface of SA/C-LMP lesions
(Figure 8). Organization began in the oldest peripheral thrombi
(closest to the remaining vessel wall), with mitotically-active
endothelial cells of budding capillaries migrating from the
adventitia into the clot. Organizing thrombi could undergo
progressive collagenization and re-canalization. In all but one
case, the re-canalized vessels were typically elongated, parallel to
the vessel wall and aligned with the flow of blood, and were lined
PLoS ONE | www.plosone.org

Myocarditis
‘‘Myocarditis’’ was listed as the cause of the earliest death in our
series (Case 1, day 10). However, unlike the few previous
descriptions of KD myocarditis, there was no myocyte degeneration or necrosis nor damaged intra-mural vessels. The two most
striking myocardial features of this unique KD case were the
abundance of mature eosinophils and the marked intercellular and
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Table 3. Newly described pathologic features observed in the 41 KD patients.

Acute neutrophilic necrotizing arteritis (NA) causes the saccular aneurysms that fatally rupture or thrombose within the first month after onset; survival can be followed
by superimposed thrombotic episodes or progressive coronary insufficiency that can be fatal at any time.
NA involves medium sized muscular and elastic arteries but not veins, pulmonary arteries, and apparently not the aorta.
Severe subacute/chronic (SA/C) vasculitis can cause saccular aneurysms that can fatally thrombose (but apparently not rupture) in the first two months and thereafter;
persistent SA/C may account for morbidity and mortality from worsening of CAA months and years after acute KD in some cases [67].
The intra-luminal stenosing lesions caused by luminal myofibroblastic proliferation (LMP) contain smooth muscle cell (SMC)-derived pathologic myofibroblasts that
produce extracellular matrix (ECM) products in a background of SA/C inflammatory cells (SA/C-LMP).
LMP can also occur in areas remote from active SA/C inflammation, possibly due to circulating factors.
SA/C-LMP lesions do not undergo organization or re-canalization nor represent granulation/scar tissue.
Transformation of medial SMC into myofibroblasts has been hypothesized but it required the TEM performed in this study to be confirmed.
Adventitial SMC can apparently replace medial SMC and can also transform directly into myofibroblasts, when medial SMC are lacking.
SA/C and SA/C-LMP also involves veins, pulmonary arteries, and the aorta, but apparently only to a relatively mild, subclinical degree.
SA/C inflammatory cells are predominantly small lymphocytes accompanied by varying numbers of eosinophils and plasma cells, while macrophages, mast cells, and
neutrophils are rare.
The majority of lesional macrophages are apparently recruited to areas of medial and adventitial SA/C damage, where they scavenge debris and then migrate to
draining lymph nodes.
There appears to be no consistent pattern to the location, abundance, and extent of fusiform dilations, saccular aneurysms, and stenosing SA/C-LMP lesions among
cases.
Calcification occurs within organizing and organized thrombi, but not in the remaining tissue/wall of CAA.
Infarcts of the kidneys, spleen, and adrenals due to SA/C-LMP are relatively common, but were apparently not clinically evident at the time of death/transplant.
KD patients can have an interstitial ‘‘eosinophilic-type’’ myocarditis accompanied by profound edema and interstitial lymphocytes, but without myocyte degeneration
or necrosis.
Pseudo-myocarditis, from SA/C inflammation directly extending from CA pan-arteritis, is relatively common and can be misinterpreted as true myocarditis.
SA/C endocarditis appears to be a virtually universal phenomenon that can seriously involve the contiguous valves. The fibrotic endocardium frequently undergoes
elastosis consistent with endocardial fibroelastosis.
Pericarditis varies in the degree of SA/C inflammation, which is usually most concentrated over inflamed CA.
Stenosing LMP with little to no SA/C inflammation and intact elastic laminae and media can occur at ‘‘remote’’ arterial sites, suggesting that factors from active SA/C
inflammation can circulate and act widely.
Patterns of myocardial ischemia/infarction can be strikingly complex.
Patients appear capable of surviving surprisingly extensive myocardial scarring.
A spectrum of microscopic SA/C and lymphocyte/macrophage aortitis can be seen.
Eosinophilic and giant cell-like myocarditis may be associated with KD.
KD clinicopathology develops in roughly two phases: acute NA (likely the direct effect of a virus) and SA/C inflammation causing SA/C-LMP stenosis (likely immunemediated).
doi:10.1371/journal.pone.0038998.t003

perivascular edema (Figure 9D). Lymphocytes and some plasma
cells and macrophages were also seen, but only rare neutrophils.
The only cellular pathology observed in the several available
sections from the same CA/myocardium block was reversible foci
of swollen (hydropic) sub-endocardial myocytes with few contraction bands. The pronounced edema of this ‘‘eosinophilic-type’’

myocarditis would presumably have created a ‘‘flabby’’, poorly
contractile heart and likely a dysfunctional conduction system,
leading to acute heart failure. In addition to the ‘‘eosinophilictype’’ myocarditis, the section contained a figure-eight shaped CA
showed SA/C pan-arteritis, SA/C-LMP, pericarditis (especially
near the inflamed CA), and several mildly inflamed epicardial

Table 4. Pathologic observations that differ from those previously reported.

Neither granulomatous inflammation nor granulomas were detected.
Severe CAA do not ‘‘regress’’, ‘‘resolve’’, or ‘‘remodel’’, but rather they thrombose.
Neutrophils characterize NA, while lymphocytes, plasma cells, and eosinophils characterize SA/C inflammation.
Small vessel pathology is rare and mild, and involves intra-myocardial and intra-renal arteries.
There was no medial SMC hyperplasia.
There was minimal medial fibrosis/scarring.
There were no histologic features of atherosclerosis even in remote deaths or transplants.
doi:10.1371/journal.pone.0038998.t004
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Table 5. Potential clinicopathologic outcomes following infection with the KD etiologic agent.

If the child lacks the ‘‘required’’ genetics, the ubiquitous seasonal infection will likely be essentially inconsequential, i.e., just another mild respiratory illness of childhood.
In some of these individuals it may lead to ciliated bronchial cell intracytoplasmic inclusions. Whether these children harbor the putative KD agent for a prolonged
period in an immunologically controlled/suppressed state is unknown.
Some genetically predisposed children may develop some or all of the characteristic clinical signs and symptoms of KD, but no overt vasculitis.
Other predisposed children may develop the clinical features of KD with inconsequential CA vasculitis.
Others may develop CA or NCA fusiform dilations with or without aneurysms that neither rupture nor thrombose, and develop asymptomatic SA/C and SA/C-LMP,
which may progress slowly until clinically significant [68]. Echocardiography may underestimate the presence of critical SA/C-LMP CA pathology, i.e. ‘‘hidden’’ KD
vasculopathy.
At about 3–4 weeks, a very small percentage of IVIG-untreated or resistant patients die from CAA and myocardial ischemia, ruptured CA or NCA aneurysm, or
thrombosis of a NCA (Table 2).
Patients who do not die from an ‘‘acute’’ event can experience progressive LMP stenosis until they ultimately die from coronary insufficiency (Cases 25 at 4.5 months
and 27 at 7.5 months) or receive a cardiac transplant (Cases 30 at 15 months, 32 at 18 months, and 33 at 2 years); the complicated, unpredictable nature of SA/C-LMP
lesions makes coronary artery bypass grafting potentially difficult and angioplasty of variable benefit.
‘‘Stable’’ CAA may eventually accumulate enough thrombotic material to eventually cause critical myocardial ischemia.
doi:10.1371/journal.pone.0038998.t005

arteries. It is unfortunate that the aortic ‘‘aneurysms’’ described in
one autopsy report were not embedded. Though aortas could
appear grossly normal random sections often revealed histopathology. There could be mild to moderate lymphocytic inflammation of the vaso vasorum and of the wall with irregular gaps.
The intima varied from totally normal to edematous and inflamed.
Although most of the inflammatory cells were lymphocytes, some
cases had sections of aorta with focal and/or diffuse infiltrates of
CD68-positive macrophages, sometimes multinucleated, both
foreign body and Langhans types. However, features of atherosclerosis, such as lipid-laden macrophages or SMCs (foam cells),
calcium, and cholesterol were not present.

nerves (Figures 9A, B, C). The few small epicardial arteries and
veins were histologically normal. The endocardium was thickened
and showed mild SA/C inflammation and edema.
Two cases, a transplant (case 33) and an autopsy (case 19) had
extensive myocardial infarctions plus an atypical myocyte process
that resembled myocarditis. The involved myocytes and their
nuclei varied markedly in size and shape. Multiple nuclei could be
crowded together, nucleoli were typically multiple, and chromatin
had a ‘‘salt-and-pepper’’ pattern. Mitotic figures were present,
some of which were atypical, even ‘‘bizarre’’ and ‘‘anaplasticlooking’’. These unusual myocytes were not hypertrophied cells
with ‘‘box-car’’-shaped nuclei, which are frequently observed
around older myocardial infarcts. Their etiology is under
investigation.
Several other patients had a ‘‘pseudo-myocarditis’’, where SA/
C inflammatory cells spread into myocardium from contiguous
inflamed epicardial CA. There was no indication that the
infiltrated myocardium was damaged. Thus, depending on the
plane of section and/or whether the block contained CA, the
myocardium could appear inflamed (‘‘pseudo-myocarditis’’).
Multinucleated giant cells were not a feature of CA or NCA
vasculitis or vasculopathy in any of our cases [20,34].

Post-transplant Vasculopathy
One KD patient (case 30) underwent a total of three heart
transplants, the first for ischemic KD coronary vasculopathy, and
two more for ischemic post-transplant vasculopathy. The KD
heart had thrombosed CAA, while the subsequent hearts had the
CA stenosis typical of post-transplant vasculopathy, with some
similarities to KD LMP. The CA media showed the same pattern
of adventitial SMC entering the periphery of the media and
SMC/myofibroblasts exiting the opposite surface and entering the
luminal mass. TEM of coronary artery tissue retrieved from a
paraffin block from the second transplanted heart revealed SMCderived LMP-like myofibroblasts (Figure 15).
While the initial KD heart had typical SA/C vasculitis/damage
of the CA media and SA/C-LMP, the CA of the two posttransplant vasculopathy hearts showed little to no chronic
inflammation of the media or of their luminal lesions, mild medial
and IEL damage, and both lipid-laden macrophages and SMC
scattered throughout the lesions. However, the post-transplant
vasculopathy lesions lacked the calcium, cholesterol clefts,
atheromas, and multi-nucleated macrophages typical of atherosclerotic plaques.

Pericarditis and Endocarditis
All cases had some degree of pericarditis and endocarditis. The
pericardial inflammation was most intense in the vicinity of or
overlying CA undergoing SA/C pan/peri-arteritis. Foci of
granulation tissue and fibrosis and a covering of fibrinous exudate
were occasionally present.
SA/C-induced endocarditis varied in extent, lesional thickness,
fibrosis, elastosis, and inflammatory intensity. The endocarditis
could directly extend to involve valves, even resulting in their
necrosis. However, the endocarditis did not extend into the
adjacent myocardium, which frequently showed reversible hydropic degeneration and contraction bands, and even irreversible
coagulation necrosis. The degree of fibrosis (dense bands) and
density and widening of elastic fibers increased approaching the
myocardium. The endocardial lesions occasionally had a longitudinal row of SMC.

Non-vascular Pathology
A number of other intriguing, non-vascular observations were
made; these are described in Table S1.

Discussion

Aortitis

Our study reveals a three processes model of KD pathology
newly described based on the English language KD literature and
the availability of original figures in KD articles published in

The aortic findings were surprising, given the larger size of the
aorta, its prominent elastic laminae, and the apparent absence of
significant pathology of other large vessels such as the pulmonary
PLoS ONE | www.plosone.org
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Table 6. Clinical implications of this study.

IVIG treatment is likely to abrogate NA pathology and thus affect subsequent events, so early therapy is likely critical.
Since the threat of new and the extension of previous CA thrombi persists, more aggressive and prolonged anti-platelet and anti-thrombotic therapies for patients with
significant CA abnormalities may be warranted.
A study of prolonged anti-inflammatory therapy in patients with CA abnormalities should be considered, since persistent inflammation is a feature of SA/C and SA/CLMP.
Identification of therapies that interfere with the transition of SMC to myofibroblasts and progression of SA/C-LMP and LMP lesions is urgent.
Luminal narrowing from CAA thrombosis followed by calcification of organizing thrombi should aid with pathologic/radiographic interpretation.
Apparently ‘‘regressed’’ fusiform dilations are still capable of undergoing luminal narrowing by persistent SA/C and SA/C-LMP.
Endocarditis appears to be very common and can potentially cause serious valvular disease.
Endocarditis often leads to endocardial fibroelastosis, which may have a restrictive cardiac effect and requires monitoring.
Long-term survivors with significant NCA pathology may ultimately suffer some pancreatic, renal, or adrenal dysfunction.
KD vasculopathy does not appear to progress to atherosclerotic coronary artery disease.
doi:10.1371/journal.pone.0038998.t006

foreign journals (Table 3). Some of our observations appear to
directly contrast with those previously described (Table 4). Our
findings lead us to propose a range of clinicopathologic outcomes
following infection with the etiologic agent of KD (Table 5).
The fact that about two-thirds of our cases developed KD in the
post-IVIG era (after the late 1980s) attests to the continued
significance of this enigmatic disease. Although this study is by
necessity a mortality and near-mortality transplant study, it raises
the question of the scope of its undocumented long-term morbidity
and mortality. Many of our patients were diagnosed after the 10th
day of illness, and in some cases the diagnosis was not suspected
until at or near the time of death. This emphasizes the continued
critical need for a timely diagnostic test and improved treatment.
Considering the degree of arterial wall destruction due to NA
and severe SA/C panarteritis, it seems counterintuitive that the
resulting aneurysms could possibly ‘‘remodel’’, ‘‘resolve’’, or
‘‘regress’’ [33,35,36,37,38]. The aneurysmal arteries have lost
both elastic laminae, most if not all of their media, and portions of
their adventitia. The concept of ‘‘remodeling’’ or ‘‘regression’’
arises from a misinterpretation.Non-lethal thrombi variably fill
aneurysmal cavities (the apparent lumina), giving the impression
that the aneurysms are actually decreasing in size. Thus, shrinkage
of focal or ring-shaped calcifications as assessed by CA radiography actually indicates progression of the intraluminal thrombotic
process. Thus, the phenomenon of ‘‘arteries within the artery’’ is a
consequence of organization and recanalization of thrombi [39].
Echocardiography primarily images the proximal portion of the
CA and may therefore underestimate the extent of distal CA
vasculopathy. Intravascular ultrasound studies using interpretation
based on studies of atherosclerosis, a very different pathologic
process from KD, must be interpreted with caution [40,41] and
should be correlated with actual KD vasculopathy specimens; for
example, it is unlikely that LMP can be distinguished from
organizing thrombi by intravascular ultrasound.
SA/C vasculitis is almost assuredly responsible for transition of
SMC into myofibroblasts and the subsequent creation of LMP
lesions. Transforming growth factor b stimulates transition of
fibroblasts into classic wound healing myofibroblasts, but the
factors that do so for SMC transition into LMP myofibroblasts are
unknown but of great interest. Although they are ultrastructurally
very similar, LMP myofibroblasts tend to be more pleomorphic
and activated than those in wound healing. It is possible that LMP
lesions represent a form of non-resolving wound healing; persistent
inflammation associated with chronic, poorly healing wounds is
well-documented [42]. Ultimately, healing is associated with
PLoS ONE | www.plosone.org

myofibroblast apoptosis, which is not seen in LMP lesions. LMP
lesions could actually be a response to the wounding of the media
by SA/C inflammation, stimulating the SMC transition to
myofibroblasts and proliferation of luminal mesenchymal/inflammatory lesions, as if the open lumen was being interpreted as a
‘‘defect’’.
It is critical to know why the coronary arteries are always
targeted by the etiologic agent of KD in patients who develop
vasculitis, while other similar sized muscular and elastic arteries
are only variably affected. Although other arterial diseases may
involve the CA, none consistently attacks them. A likely possibility
is that there exists a heterogeneity among endothelial cells from
different body sites with regards to chemokines, adhesion
molecules, or other markers. The receptors for the KD agent
may be more prevalent on CA endothelium [43]. The intracranial
vessels are spared, while the aorta and pulmonary arteries only
undergo a minimal amount of pathology. This extraordinary CA
specificity is not observed in any other vascular disease, including
atherosclerosis, which involves one or more of the three major
arterial systems: CA, aorta, and central nervous system. KD may
serve as a model for other pathologies, especially other occlusive
vasculitides, and also for basic biologic processes.
Interstitial myocarditis has been previously reported as an acute
and subacute/chronic phenomenon in KD and may be responsible for the cardiac dysfunction commonly observed during the
acute illness, which is generally responsive to IVIG [44,45,46]. It
has been difficult to correlate the clinical diagnosis with
myocardial pathology, since there have been few published
autopsies from early in the illness. A single report of a child who
died 9 days after disease onset, presumably from an arrhythmia,
showed myocardial edema with neutrophils and lymphocytes
infiltrating from intramural micro-vessels and small arteries, but
there was no mention of myocyte damage [20]. Vascular damage
may be the cause of the edema. Some of the reported myocardial
inflammation may actually represent ‘‘pseudo-myocarditis’’ from
spillover of SA/C pan/peri-arteritis of adjacent coronary arteries
[47]. Normal serum cardiac troponin levels in the acute phase of
KD suggest that myocyte necrosis is not significant [48]. Our day
10 ‘‘eosinophilic-type’’ myocarditis fatality is both curious and
seemingly unique for KD. It remains to be determined whether
the two conditions are related to the same etiologic agent. It is
unclear whether the ‘‘myocarditis’’ seen in endocardial biopsies
months to years after KD onset might either be due to ischemia or
endocarditis [49].
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While KD is rare in healthy adults, it may be more prevalent in
immunocompromised individuals, e.g. human immunodeficiency
virus/acquired immunodeficiency syndrome (HIV/AIDS)
[50,51,52,53,54,55]. At least 20 HIV/AIDS adult patients
(average age of38 years) (CD4 lymphocyte counts less than 200/
mm3 in 17 patients and most with high viral loads) have been
reported as having presented with KD-like clinical signs and
symptoms, although none apparently developed documented CA
pathology [50]. Recurrence of KD symptoms was reported in 5 of
the 20 patients. A child with HIV infection who developed
myocardial infarction due to thrombosis of a right coronary artery
aneurysm was has been reported [56]. If HIV/AIDS does increase
the risk of developing KD, could any immunodeficient patient
experience reactivation of an immunologically sequestered KD
agent that was associated with a previous asymptomatic or
symptomatic childhood infection that persisted dormantly? Alternatively, could immunodeficiency modify the genetic influences on
KD susceptibility?
Cells identified as ‘‘myofibroblasts’’ (based only on IHC for
SMA) in animal models of coronary injury and following coronary
angioplasty and intracoronary stent placement have been considered to derive from adventitial fibroblasts. Medial SMC,
endothelial cells, circulating bone marrow-derived fibrocytes,
pericytes, and mesenchymal stem cells have also been proposed
as possible sources [57,58,59]. In a rat carotid artery injury model,
the cell of origin was considered to be an adventitial myofibroblast
[60]. However, a recent study using bromodeoxyuridine tracing to
identify the neo-intimal cells in a swine balloon angioplasty model
concluded that they are of SMC origin [61]. Since atherosclerosis
is considered to be an inflammatory process with medial SMC
[62] and even myofibroblasts [63] as important plaque components, correlative LM, IHC, and TEM studies are necessary to
determine if these cells are truly related to the classic myofibroblast
of wound healing, and if there is a relationship to SA/C
inflammation and SA/C-LMP vasculopathy.
Previous LM studies of post-transplant vasculopathy (PTV)
concluded that both proliferating SMC and ‘‘myofibroblasts’’
comprise its neo-intima [64]. It was of great interest to be able to
study the KD heart and two subsequent transplanted hearts from
the same patient. There were both similarities and differences
between the PTV and KD vasculopathy. The TEM of the PTV
CA revealed myofibroblasts identical to those in KD LMP, as well
as the same ‘‘in-and-out’’ pattern of adventitial SMC entry to the
media and transition of medial SMC into myofibroblasts.
However, PTV differed from KD in its lack of SA/C inflammation, its virtual preservation of the media, the more fibrotic and
less cellular obstruction, and luminal lesions that contained both
foamy macrophages and SMC. These observations suggest the
possibility that pathologic myofibroblasts may not be restricted to
the occlusive vasculopathy of KD.
A number of potentially important clinical implications derive
from this study (Table 6). Employing the three process model for
KD vasculopathy greatly facilitated our ability to perform

clinical:pathologic and radiographic:pathologic correlation, both
for our cases and published cases. We believe that a key to
advancing our understanding of this enigmatic disease is to
establish a multi-functional ‘‘Kawasaki Disease Center’’ to collect
clinical, pathologic, laboratory, and radiographic data from as
many diagnosed patients as possible; collect tissue and fluid
specimens for study, teaching, and research; provide timely
diagnostic and clinical assistance; and offer educational opportunities for clinicians, pathologists, and researchers. Establishing a
full time ‘‘Registry, Repository, Diagnostic, and Educational
Center’’ seems a worthy objective. Thorough gross and microscopic autopsy and transplanted heart examination using specifically designed protocols with extensive digital camera documentation is critical. All CA and medium-sized NCA must be ‘‘breadloafed’’ for both gross and microscopic examination since mural
and luminal vasculopathy due to SA/C, SA/C-LMP, and LMP
can involve vessels that appear normal on gross examination.
Clinically significant SA/C, LMP, and SA/C-LMP lesions can be
observed in persistent and recoiled fusiform dilations [65].
Representative normal and pathologic specimens fixed for light
and transmission electron microscopy as well as appropriately
frozen specimens are critical. Careful examination of specimens
from deaths of individuals with documented histories of KD, who
apparently did not die from the disease is of enormous importance.
Likewise is the study of specimens from individuals without a
known KD history, but who die from CA pathology that is not
typical of atherosclerosis, such as thrombosed or ruptured CAA or
non-atheromatous-type luminal stenosis [66]. The younger the
individual, the greater the possibility that the individual might
have had undiagnosed KD.
It is critical that the KD etiologic agent be identified, isolated,
and propagated, so that we can understand the pathogenesis,
derive a rapid diagnostic test, identify effective acute and chronic
therapy, and make prevention possible.
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